ICI 215,001 hydrochloride
Cat. No. 0929
Chemical Name: (S)-4-[2-Hydroxy-3-phenoxypropylami
Biological ActivityThe active metabolite of ZD 7114 (Cat. No. 0930).
Licensing InformationSold with the permission of AstraZeneca UK Ltd.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
on-line. Please contact Customer Service
How (1993) β3Adrenergic agonists. Drugs Future 18 529.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for ICI 215,001 hydrochloride include:
Littmann et al (2015) Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands. PLoS One 355 183. PMID: 26306764.
Suárez et al (2014) Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. Dis Model Mech 7 129. PMID: 24159189.
Do you know of a great paper that uses ICI 215,001 hydrochloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: ICI 215,001 hydrochloride, supplier, β3-adrenoceptor, b3-adrenoceptor, β3-adrenergic, b3-adrenergic, agonists, Receptors, ICI215001, hydrochloride, AstraZeneca, Tocris Bioscience, Adrenergic β3 Receptor Agonist products
Find multiple products by catalog number
April 1 - 5, 2017
Washington, D.C., USA